Rapid steroid withdrawal versus standard steroid therapy in patients treated with basiliximab, cyclosporine, and mycophenolate mofetil for the prevention of acute rejection in renal transplantation
- 1 February 2001
- journal article
- clinical trial
- Published by Elsevier in Transplantation Proceedings
- Vol. 33 (1-2) , 1011-1012
- https://doi.org/10.1016/s0041-1345(00)02308-3
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- PREDNISONE WITHDRAWAL IN KIDNEY TRANSPLANT RECIPIENTS ON CYCLOSPORINE AND MYCOPHENOLATE MOFETIL-A PROSPECTIVE RANDOMIZED STUDY1,2Transplantation, 1999
- PROLONGED ACTION OF A CHIMERIC INTERLEUKIN-2 RECEPTOR (CD25) MONOCLONAL ANTIBODY USED IN CADAVERIC RENAL TRANSPLANTATIONTransplantation, 1995
- INHIBITION OF ALLORESPONSIVE NAIVE AND MEMORY T CELLS BY CD7 AND CD25 ANTIBODIES AND BY CYCLOSPORINETransplantation, 1990
- PREVENTION OF REJECTION OF KIDNEY TRANSPLANTS BY MONOCLONAL ANTIBODY DIRECTED AGAINST INTERLEUKIN 2The Lancet, 1987